{"certainAgreement":{"otherDetails":"The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of pooled data (i.e.,data from all sites) in clinical trial or disclosure of trial results in their entirety.","piSponsorEmployee":false,"restrictionType":"OTHER","restrictiveAgreement":true},"limitationsAndCaveats":{"description":"230 patients evaluated in the Full Analysis Set: 79 randomized to LDE225 (Sonidegib) 200mg group \\& 151 randomized to LDE225 800mg group. 1 patient randomized to the 800mg group did not receive study treatment \\& thus was not counted in the Safety Set."},"pointOfContact":{"email":"Novartis.email@novartis.com","organization":"Novartis Pharmaceuticals","phone":"862-778-8300","title":"Study Director"}}